School of Medicine Faculty of Medicine Internal Medicine 3(Divisions of Cardiology Hematology & Rheumatology)
Assistant Professor
竹村 兼成
TAKEMURA Tomonari

Last updated: 2025/05/02
Research activities
Papers
[1]. Prognostic impact of the dosage of methotrexate combined with tacrolimus for graft-versus-host disease prophylaxis after cord blood transplantation.
International journal of hematology [Volume]114 [Issue]2 [Page]252 -262 (2021/) [DOI]
[2]. [Sarcoidosis-lymphoma syndrome showing abnormal FDG uptake in lymph nodes and muscles upon post-chemotherapy PET/CT imaging].
[Rinsho ketsueki] The Japanese journal of clinical hematology [Volume]60 [Issue]4 [Page]302 -307 (2019/) [Reviewed] Yes [DOI]
[3]. Acquired factor X deficiency developed four years after autologous transplantation in a patient with multiple myeloma associated with systemic AL amyloidosis.
[Rinsho ketsueki] The Japanese journal of clinical hematology [Volume]55 [Issue]5 [Page]558 -62 (2014/) [Reviewed] Yes
[4]. JmjC-domain containing histone demethylase 1B-mediated p15(Ink4b) suppression promotes the proliferation of leukemic progenitor cells through modulation of cell cycle progression in acute myeloid leukemia.
Molecular carcinogenesis [Volume]52 [Issue]1 [Page]57 -69 (2013/) [Reviewed] Yes [DOI]
[5]. Down-regulation of Thanatos-associated protein 11 by BCR-ABL promotes CML cell proliferation through c-Myc expression.
International journal of cancer [Volume]130 [Issue]5 [Page]1046 -59 (2012/) [Reviewed] Yes [DOI]
Bibliography
[1]. 2020/ ESHAP/R-ESHAP療法.悪性リンパ腫治療マニュアル 南江堂
Research presentations
[1]. 2020/3/ Efficacy of allogeneic hematopoietic stem cell transplantation for malignant lymphoma.
[2]. 2019/10/ 胃腺腫に対して内視鏡的粘膜下層剥離術を施行した第V因子欠乏症の1例 臨床血液
[3]. 2019/5/ 多発性骨髄腫患者に対する自家移植後の地固め療法のリスクとベネフィット(Risks and benefits of consolidation therapy after autologous stem cell transplantation for multiple myeloma) International Journal of Myeloma
[4]. 2018/9/ 多発性骨髄腫におけるMRD測定による自家移植の治療効果評価(Evaluation based on minimal residual disease after autologous stem cell transplantation in myeloma) 臨床血液
[5]. 2018/9/ 同種造血幹細胞移植患者におけるMRワクチンの反応性(Immune response to MR vaccine in allogeneic hematopoietic stem cell transplantation recipients) 臨床血液